BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6119643)

  • 1. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
    Borison RL; Fields JZ; Diamond BI
    Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
    [No Abstract]   [Full Text] [Related]  

  • 2. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
    Bartholini G
    Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
    Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
    Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
    [No Abstract]   [Full Text] [Related]  

  • 4. Central nervous system dopamine receptors.
    Creese I
    Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
    Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
    Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for the existence of multiple receptors for dopamine in the central nervous system.
    Iversen LL; Quik M; Emson PC; Dowling JE; Watling KJ
    Adv Biochem Psychopharmacol; 1980; 21():193-202. PubMed ID: 6103646
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
    Clement-Cormier Y
    Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of chronic neuroleptic administration on cerebral dopamine receptor function.
    Rupniak MN; Jenner P; Marsden CD
    Life Sci; 1983 May; 32(20):2289-311. PubMed ID: 6133203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
    Baldessarini RJ; Tarsy D
    Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors.
    Katzman R; Makman MH; Ahn HS; Mishra RK; Gardner E
    Trans Am Neurol Assoc; 1977; 102():76-9. PubMed ID: 98893
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evidence for multiple dopamine receptors in man.
    Meltzer HY
    Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of chlorpromazine on dopaminergic receptor functions in rat brain--difference of the response of several dopaminergic systems after chronic administration (author's transl)].
    Kaneno S
    Seishin Shinkeigaku Zasshi; 1980 Jun; 82(6):335-52. PubMed ID: 7465695
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of brain dopamine].
    Rybakowski J
    Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dopamine hypothesis in schizophrenia--recent findings in limbic system abnormality].
    Toru M; Watanabe S; Kaneno S
    Nihon Rinsho; 1978; 36(1):76-82. PubMed ID: 24768
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
    Havemann U
    Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic effects in Tourette syndrome predict dopamine excess and acetylcholine deficiency.
    Stahl SM; Berger PA
    Biol Psychiatry; 1982 Sep; 17(9):1047-53. PubMed ID: 6128037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
    Aksent'ev SB; Mokhovikov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.